Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer.
- DOI
- 10.3390/ph13110386
- Published
- 2020 Nov 13
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph13110386,
title = {Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer.},
author = {Ekpenyong O and Cooper C and Ma J and Guy NC and Payan AN and Ban F and Cherkasov A and Cox MB and Liang D and Xie H},
year = {2020},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph13110386},
url = {https://doi.org/10.3390/ph13110386}
}RIS
TY - JOUR TI - Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer. AU - Ekpenyong O AU - Cooper C AU - Ma J AU - Guy NC AU - Payan AN AU - Ban F AU - Cherkasov A AU - Cox MB AU - Liang D AU - Xie H PY - 2020 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph13110386 UR - https://doi.org/10.3390/ph13110386 ER -
APA
O, E., C, C., J, M., NC, G., AN, P., F, B., A, C., MB, C., D, L., & H, X. (2020). Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph13110386
Source records
- pubmed · retrieved 2026-09-26T09:59:15.511Z